Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xyrem in Fibromyalgia
NCT00423813Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Dec 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of sodium oxybate in fibromyalgia (FM), sponsored by Jazz Pharmaceuticals plc. Started Dec 2006; status: completed.
02
Drugs
sodium oxybate
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00423813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00423813.